Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Clozapine in Translational Schizophrenia Research: Mechanism
2026-04-30
Clozapine’s unique pharmacological profile—marked by high-affinity antagonism of serotonin and dopamine receptors, and activation of ERK1/2 signaling via EGF receptor pathways—makes it a critical tool for translational schizophrenia research. This article synthesizes mechanistic insight, experimental guidance, and the evolving competitive landscape, integrating recent findings on neuromodulation (e.g., targeted magnetic stimulation of the prefrontal cortex) to inform best practices for translational researchers. APExBIO’s Clozapine is highlighted for its reliability, and actionable protocol parameters are provided.
-
Optimizing Reporter Assays: Advanced Use of EZ Cap™ Firefly
2026-04-30
Explore how Firefly Luciferase mRNA (5-moUTP) enables ultra-sensitive, sustained bioluminescent reporter assays. This article uniquely integrates technical advances in mRNA stabilization and immune evasion with actionable assay design insights.
-
Y-27632: Precision ROCK Inhibition for Immuno-Oncology Resea
2026-04-29
Explore the advanced use of Y-27632 as a selective ROCK inhibitor in immuno-oncology research. This guide provides nuanced insights into cytoskeletal dynamics modulation, T cell function, and metastasis, distinguishing its role from traditional cell biology uses.
-
CHIR-99021 (CT99021): Driving Stem Cell Pluripotency and Fat
2026-04-29
CHIR-99021 (CT99021) is a benchmark GSK-3 inhibitor, enabling robust modulation of Wnt/β-catenin and TGF-β/Nodal pathways for precise stem cell fate control. This article details experimental workflows, advanced applications in differentiation, and troubleshooting insights, empowering researchers to maximize reproducibility and efficiency in cell-based assays.
-
Sumatriptan Succinate: Anti-Inflammatory Actions Beyond Migr
2026-04-28
Ala et al.'s systematic review consolidates evidence that Sumatriptan Succinate, a well-established 5-HT1B/1D receptor agonist for migraine, also exerts significant anti-inflammatory effects across a range of experimental models. These findings broaden the molecule's research utility in neurovascular and inflammatory pathway studies, informing assay design and translational research.
-
Recombinant Mouse M-CSF: Metabolic Macrophage Control in Fib
2026-04-28
Explore how Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag enables advanced control of macrophage metabolism and polarization in fibrotic models. This article bridges recent molecular discoveries with practical assay guidance, setting a new benchmark for translational research.
-
Lamotrigine in Translational Research: Mechanism, Models, an
2026-04-27
This article explores the multifaceted translational applications of Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine), with a focus on mechanistic insight, high-throughput blood-brain barrier (BBB) modeling, and strategic workflow integration for epilepsy and cardiac sodium current research. It critically interprets evidence from recent surrogate BBB model advances, distinguishes APExBIO’s product as a benchmark for reproducibility, and offers actionable recommendations for next-generation assay design. The discussion uniquely bridges BBB permeability science with practical assay deployment, surpassing typical product summaries by synthesizing protocol guidance with translational foresight.
-
Targeted Magnetic Stimulation Modulates GABAA ε for Schizoph
2026-04-27
This study demonstrates that selective magnetic stimulation of the left prelimbic cortex in mice downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits. The findings highlight Gabre as a promising target for therapeutic intervention and advance mechanistic understanding of neuromodulation in schizophrenia models.
-
Escitalopram in Antidepressant Research: Workflows & Insight
2026-04-26
Escitalopram, the S-(+)-enantiomer of citalopram, stands out for its high selectivity and consistency in neuromodulation studies. This guide details step-by-step SSRI assay workflows, advanced troubleshooting, and data-driven protocol enhancements for reproducible antidepressant and anxiolytic research.
-
Phenylmethanesulfonyl Fluoride (PMSF): Optimizing Serine Pro
2026-04-25
Phenylmethanesulfonyl fluoride (PMSF) is the gold-standard irreversible serine protease inhibitor for preserving protein integrity during extraction and Western blot preparation. This guide translates the latest research—including insights from SARS-CoV-2 macrophage infection models—into actionable protocols, troubleshooting strategies, and advanced applications for researchers seeking robust proteomic fidelity.
-
Bradford Protein Assay Kit: Rapid, Sensitive Protein Quantif
2026-04-24
The Bradford Protein Assay Kit (SKU K4103) provides a straightforward, rapid solution for accurate protein quantification in research workflows where high sensitivity and quick turnaround are essential. It is best applied to assays requiring reliable concentration measurements from small samples and is not suited for use with protein samples containing interfering detergents or chemicals not supported by the Bradford chemistry.
-
Cimetidine (SKU B1557): Reliable Solutions for Cell Assays
2026-04-24
This article provides an evidence-based, scenario-driven exploration of Cimetidine (SKU B1557) for cell viability, proliferation, and cytotoxicity assays. Addressing real laboratory challenges, it demonstrates how Cimetidine’s unique pharmacological profile, high purity, and robust solubility from APExBIO support reproducible and sensitive experimental workflows.
-
Degarelix Acetate in Prostate Cancer: Rapid Castration Witho
2026-04-23
The reference study establishes degarelix acetate as a third-generation GnRH antagonist that enables rapid and sustained medical castration in prostate cancer patients, circumventing the testosterone surge commonly seen with GnRH agonists. Its safety and efficacy profile positions degarelix as a significant advance in androgen deprivation therapy, supporting precision in clinical management.
-
Thiothixene in Macrophage Efferocytosis: Pathways and Resear
2026-04-23
Explore how the typical antipsychotic agent Thiothixene uniquely drives in vitro macrophage efferocytosis via vitamin A signaling, with profound implications for both schizophrenia treatment and immunology research. This article uncovers advanced mechanistic insights and practical assay guidance.
-
Innovations in In Vitro Drug Response Evaluation for Cancer
2026-04-22
Schwartz's dissertation introduces a refined framework for evaluating anti-cancer drugs in vitro by distinguishing between relative and fractional cell viability. This dual-metric approach provides nuanced insights into how compounds like Axitinib (AG 013736) modulate proliferation and cell death, improving the predictive value of preclinical models for cancer therapy.